Harpoon Therapeutics has raised $45 million in its second funding round as it looks to get its I-O candidates into the clinic as well as boosting its pipeline…

In our EuroBiotech roundup this week, investor spurns a £500 million offer, Actelion tees up a $230 million J&J decision and more.

GW Pharma's cannabis-based epilepsy treatment Epidiolex is firmly on track for a filing in the U.S. after new data published in the New England Journal of…

Redx has suspended trading of its shares after a creditor stepped up its attempt to recoup a loan.

The big China CRO WuXi Biologics is slated for an initial public offering of up to $513 million in Hong Kong.

OrphoMed gained a $39 million early funding boost from a Japanese big pharma and a host of VCs as it looks to push on with work on its leading med for forms of…

The U.K. has been closing the gap on life sciences sectors in Boston and San Francisco, but uncertainty caused by Brexit may undermine those efforts, said the…

​​​​​​​Cel-Sci’s pitch to get a partial clinical hold lifted by the FDA has gone awry.

Pierre Fabre, the second biggest biopharma in France (after Big Pharma Sanofi), is boosting its cancer pipeline with what it is dubbing “promising” immuno-…

Biotech